-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Ελλάδα
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
White Paper
Innovating a Pharma Commercial Model for the Future
As pharma companies look ahead to the next decade of launches, it's time to think big picture about how you can engage with your customers
Oct 14, 2024
As commercial pharma leaders implement 2025 strategy, it's already time to start envisioning the next long-term horizon of strategic growth and investment. It's an opportunity to pause, consider which efforts at modernizing the commercial model have worked and what has remained the same, and chart the course for future evolution.
Pharma companies can redefine what their future looks like for the next decade, not just the next launch; it's a time to do big-picture thinking about throughput of R&D spending, gross-to-net accounting, and commercial models in order to future-proof the organization.
In this white paper, IQVIA experts discuss why the innovative commercial models of the future should be built upon a foundation of comprehensive, connected data, with flexible and dynamic allocation of sales and marketing resources, that can drive personalized content and channel orchestration for physicians at the individual and local level.
This introductory piece is the first in a series of white papers on the “Future of Pharma Commercial Models”. In subsequent works, IQVIA experts will go deeper into multiple innovative commercial model designs and share our POV.
Related solutions
Agile Brand Promotion
The customer engagement model of the future is personalized, insight-driven, and dynamic.
Brand & Marketing
Grow your brand, now and through patent expiry